Jenna Hart Burton

Jenna Hart Burton

Associate Professor of Clinical and Associate Researcher and Assistant Research Scientist

Surgical & Radiological Sciences

    Phone Number
Office
131 CCAH, Davis, CA 95616

Licenses
Diplomate, American College of Veterinary Internal Medicine (Oncology)
California veterinary license (#20646)
Education
1994, BA, Bowdoin College, Brunswick, Maine
2006, DVM, The Ohio State University, Columbus, Ohio
2011, MS, Colorado State University, Fort Collins, CO
Active Research Grants
Principal Investigator, K12 Paul Calabresi Career Development Award: Contributions of B-cell Lymphoma Microenvironment in the Development of Drug Resistance, (Principal Investigator),
Principal Investigator, COTC 021/022: Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs in the Adjuvant Setting with Osteosarcoma, (Principal Investigator), Morris Animal Foundation
Co-Principal Investigator, Use of diphenhydramine to reduce infusion-related ventricular arrhythmias in dogs treated with doxorubicin, Joshua Stern (Principal Investigator), Center for Companion Animal Health
Principal Investigator, Pharmacokinetics of oral chlorambucil in cancer-bearing cats, (Principal Investigator), UC Davis Center for Companion Animal Health
Co-Investigator, Evaluation of transarterial embolization of hepatic neoplasia, William T.N. Culp (Principal Investigator), UC Davis Center for Companion Animal Health
Co-Investigator, Outcome and Transrectal Ultrasound use in Canine Urethral Stent Cases, William T.N. Culp (Principal Investigator), UC Davis Center for Companion Animal Health
Co-Investigator, Evaluation of miRNA Concentrations in Dogs with Prostate Neoplasia, William T.N. Culp (Principal Investigator), UC Davis Center for Companion Animal Health
Co-Investigator, Use of prostatic aspirate culture to identify bacterial infection in dogs with prostatic neoplasia, Katherine Skorupski (Principal Investigator), UC Davis Center for Companion Animal Health
Co-Investigator, Pharmacokinetic analysis of vinblastine in tumor bearing cats and analysis of population covariates, Luke Wittenburg (Principal Investigator), UC Davis Center for Companion Animal Health
Principal Investigator, Enhanced Tumor Permeation and Retention of a Nanoformulation of Doxorubicin, (Principal Investigator), UC Davis Center for Companion Animal Health
Honors and Awards
1993 Franklin Delano Roosevelt Award, Bowdoin College
2006 Excellence in Ophthalmology Student Award, The Ohio State University College of Veterinary Medicine
2006 Excellence in Small Animal Medicine Student Award, The Ohio State University College of Veterinary Medicine
2006 American Association of Feline Practitioners Senior Student Award, The Ohio State University College of Veterinary Medicine
2007 Outstanding Small Animal Intern SCAVMA, Colorado State University
2008 Outstanding Specialty Resident, SCAVMA, Colorado State University
2009 Outstanding Resident, Phi Zeta Honor Society, Colorado State University
2011 Resident Research Abstract Award, ACVIM Forum, Denver, Colorado
2012 Phi Zeta Clinical Sciences Research Award
2016 UC Davis Dean's Team Award for Excellence
Most Recent Five Book Chapters
2014 Burton JH, Khanna C : The role of clinical trials in veterinary oncology, Smith A, (ed), Veterinary Clinics of North America, . 977-87.
2011 Burton JH : Chemotherapy for the feline cancer patient, Little S, (ed), The Cat: Clinical Medicine and Management, St. Louis, MO. .
Research Focus
Comparative and translational oncology, canine lymphoma
Specialty Focus
Veterinary medical oncology
Ten Recent Publications

2018
Gemignani F, Mayhew PD, Giuffrida MA, Palaigos J, Runge JJ, Holt DE, Robertson NA, Seguin B, Walker M, Singh A, Liptak JM, Romanelli G, Martano M, Boston SE, Lux C, Busetto R, Culp WTN, Skorupski KA, Burton JH
Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991–2014)

2017
Demas I, Burton JH, Post G, Kristal O, Gauthier M, Borrego JF, Di Bella A, Lara-Garcia A
Clinical presentation, treatment and outcome in 31 dogs with presumed colorectal lymphoma (2001-2013)

2017
Halsey CH, Thamm DH, Weishaar KM, Burton JH, Charles JB, Gustafson DL, Avery AC, Ehrhart EJ
Expression of phosphorylated KIT in canine mast cell tumor

2016
Schmidt AF, Nielen M, Withrow SJ, Selmic LE, Burton JH, Klungel OH, Groenwold RH, Kirpensteijn J
Chemotherapy effectiveness and mortality prediction in surgically treated osteosarcoma dogs: A validation study

2016
Saba C, Paoloni M, Mazcko C, Kisseberth W, Burton JH, Smith A, Wilson-Robles H, Allstadt S, Vail D, Henry C, Lana S, Ehrhart EJ, Charles B, Kent M, Lawrence J, Burgess K, Borgatti A, Suter S, Woods P, Gordon I, Vrignaud P, Khanna C, LeBlanc AK
A comparative oncology study of Iniparib defines its pharmacokinetic profile and biological activity in a naturally-occurring canine cancer model.